* Thorne Healthtech Inc THRN.OQ THRN.O is expected
to show a
rise in quarterly revenue when it reports results on November
9.
* The Summerville South Carolina-based company is expected
to
report a 32.1% increase in revenue to $63.44 million from
$48.01 million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Thorne Healthtech
Inc is
for earnings of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Thorne
Healthtech
Inc is $8, above its last closing price of $4.72.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.00 0.00 -0.11 Missed -2,100
Mar. 31 2022 0.10 0.10 0.09 Missed -6.9
Dec. 31 2021 0.04 0.03 0.06 Beat 100
Sep. 30 2021 -0.03 -0.03 0.01 Beat 130.8
This summary was machine generated November 8 at 03:07 GMT. All
figures in US dollars unless otherwise stated